Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederclinicaltrials.gov
ClinicalTrials.gov: Olutasidenib | Last update posted in the last 14 days
Get the latest updates from ClinicalTrials.gov: Olutasidenib | Last update posted in the last 14 days directly as they happen.
Follow now < 10 followers
Latest posts
Last updated 3 days ago
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
8 days ago
Conditions: Acute Myeloid Leukemia; Myelodysplastic Syndrome Interventions: Procedure: Allogeneic Hematopoietic Stem Cell...
Olutasidenib Combined With Co-targeted Therapy in Relapsed or Refractory IDH1-mutated Myeloid Malignancies Harboring Activated Signaling Pathway Mutations
8 days ago
Conditions: Targeted Therapy; IDH1-Mutated Malignancies; Mutations Interventions: Drug: Olutasidenib; Drug: Cladribine (CLAD)...
A Phase 2 Study Evaluating Olutasidenib in Combination With Hypomethylating Agents in Patients With IDH1-mutated Higher-risk Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Advanced Myeloproliferative Neoplasm
9 days ago
Conditions: Chronic Myelomonocytic Leukemia; Advanced Myeloproliferative Neoplasms; IDH1-mutated Higher-Risk Myelodysplastic Syndromes Interventions...
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
10 days ago
Conditions: Acute Myeloid Leukemia; Myelodysplastic Syndrome Interventions: Procedure: Allogeneic Hematopoietic Stem Cell...
A Phase II Open-label Study of Olutasidenib Post-transplant Maintenance Therapy for Patients With IDH1-mutated Myeloid Malignancies
11 days ago
Conditions: Myeloid Malignancies Interventions: Drug: Olutasidenib Sponsors: M.D. Anderson Cancer Center Recruiting
Phase 1b/2 Study of Decitabine and Venetoclax in Combination With the Targeted Mutant IDH1 Inhibitor Olutasidenib
11 days ago
Conditions: Mutant IDH1 Inhibitor Olutasidenib Interventions: Drug: Olutasidenib; Drug: Venetoclax; Drug: Decitabine...
A Phase 2 Study Evaluating Olutasidenib in Patients With IDH1-mutated Clonal Cytopenia of Undetermined Significance and Lower-risk Myelodysplastic/Syndromes/Chronic Myelomonocytic Leukemia.
11 days ago
Conditions: Myelodysplastic Syndromes; Chronic Myelomonocytic Leukemia; Clonal Cytopenia of Undetermined Significance Interventions...
Olutasidenib Combined With Co-targeted Therapy in Relapsed or Refractory IDH1-mutated Myeloid Malignancies Harboring Activated Signaling Pathway Mutations
11 days ago
Conditions: Targeted Therapy; IDH1-Mutated Malignancies; Mutations Interventions: Drug: Olutasidenib; Drug: Cladribine (CLAD)...
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
16 days ago
Conditions: Acute Myeloid Leukemia; Myelodysplastic Syndrome Interventions: Procedure: Allogeneic Hematopoietic Stem Cell...
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
24 days ago
Conditions: Acute Myeloid Leukemia; Myelodysplastic Syndrome Interventions: Procedure: Allogeneic Hematopoietic Stem Cell...
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
30 days ago
Conditions: Acute Myeloid Leukemia; Myelodysplastic Syndrome Interventions: Procedure: Allogeneic Hematopoietic Stem Cell...
Testing the Use of an IDH1 Inhibitor, Olutasidenib, in Acute Myeloid Leukemia Added to ASTX727 and Venetoclax; in High-Risk MDS Added to ASTX727; and Alone in Low Risk MDS (A MyeloMATCH Treatment Substudy)
about 1 month ago
Conditions: Acute Myeloid Leukemia; Myelodysplastic Syndrome Interventions: Procedure: Biospecimen Collection; Procedure: Bone...